Over the last two decades, the Pharmaceutical/Biotech industry has undergone radical changes. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biologics have seen a surge in the externalization and outsourcing activities. As the industry is lookin...
-
How fast the market of your interest is growing?
Key drivers behind the growth..
-
What are your biggest Challenges?Identify the key problems.. -
What are your Revenue pockets?Areas you need to bet.. -
What are your Competitors doing?Know your competitive edge.. -
Who is your Customer?Get Their changing preferences..
what we offer
Report Store
Healthcare is an ever changing domain with an explosion in knowledge and breakthrough discoveries. Hence, it has become a major thrust area for the global giants in the pharmaceutical, biotechnology and medical devices industries and also for corporates involved in research and development of new products.
IQ4I's focus areas in Healthcare include Pharmaceuticals, biotechnology, Medical devices and Healthcare IT. Since these domains cater to humans, they are subject to stringent regulatory mechanisms requiring highly specialized skills in knowledge processing, with superior quality and adherence to global standards.
IQ4I
Latest Reports
Over the last two decades, the Pharmaceutical/Biotech industry has undergone radical changes. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biologics have seen a surge in the externalization and outsourcing activities. As the industry is looking for new sources of discovery and innovation with limited resources, there is a growing preference to move towards externalization and willingness to embrace the concept of outsourcing.
IQ4I estimates that ~16% of the pharmaceutical/biotech R&D spending was allocated to outsourcing. Almost all the major Pharmaceutical companies are considering outsourcing as a core strategy to fill their discovery pipelines. Contract Research Organisation (CRO) that have precise capabilities through greater flexibility are the preferred ones. Now–a–days, the big pharma relies more on CRO’s for drug discovery capabilities to stock up their pipelines.
The growth pharmaceutical market can be attributed to various factors, like increasing global population, a rise in chronic diseases such as infectious diseases, oncology, and cardiovascular disorders, as well as a significant increase in healthcare expenditures. Increasing the trend of outsourcing manufacturing to CMOs is beneficial for both pharmaceutical companies and the service providers. It allows pharmaceutical companies to focus on their core competencies while leaving the manufacturing responsibilities to specialized CMOs. This trend is favoring contract manufacturing service providers and is expected to increase the share in the pharmaceutical manufacturing market. Contract pharmaceutical manufacturing services are mainly focused on the manufacturing of Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF).
Respiratory disease is the diseases and disorders of the airways and the lungs that affect human respiration. Respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), sleep apnea and others may be caused by infection, by smoking tobacco, or by breathing in second hand tobacco smoke, radon, asbestos, or other forms of air pollution. Respiratory care device are used for the diagnosis, treatment and monitoring of Respiratory diseases. These devices help patients in need of support for breathing, removal of carbon dioxide, and therapy to reduce disuse atrophy of abdominal wall muscles. Technological advancements in respiratory care devices and funding for the development of innovative respiratory technologies further boost the growth of market.
Glucose Monitoring consists of products that are essential for measuring glucose levels in diabetes patients. With the projected rise in the aged population and awareness about diabetes conditions, the market is focused on growing with newer technology and improved products. According to IQ4I analysis, the glucose monitoring global market is expected to grow at a double digit CAGR from 2022 to 2029 reach $33,886.4 million by 2029.
Heart failure is a condition in which the heart is unable to pump enough blood to meet the body's needs; it can be either an acute or chronic condition. Some of the common causes of heart failure include coronary artery disease, heart attack, high blood pressure, atrial fibrillation, valvular heart disease, and cardiomyopathy. Factors such as increasing incidence of heart failure diseases, technological advancement in heart failure devices, rising geriatric population, and favorable reimbursement are the drivers, vast pipeline products, increase in funding and approvals are the opportunities.
Neuromodulation is the alteration of nerve activity through the delivery of an electric and magnetic stimulus. Applications for neuromodulation include therapies for a wide range of disorders, as well as a tool for medical and neuroscientific research. It is used as a treatment for unmanageable chronic pain, movement disorders, neurological diseases, gastroenterology, respiratory related diseases and others. The treatment delivered by neuromodulation devices brings about life-changing transformation in patients who fail to get better by traditional approaches. This therapy is based on the natural process of stimulation of nerve cell activity and release of neurotransmitters that regulate nerve activity.
Pharmaceutical excipients are inactive substances in the drug which help in modulating the solubility, bioavailability, and stability of active substances for formulating final drug dosage forms. The excipients form the major part of any medicinal product and the proportion of it, when compared to Active Pharmaceutical Ingredient (API), exceeds two to three folds in any pharmaceutical preparations. Hence, various characteristics such as functionality, regulatory status, sources, cost, consistency, bioavailability, physicochemical properties, stability, pharmacokinetic parameters, etc. play a major role in determining the suitability of a substance as an excipient.
Each drug is made up of two components that are API and excipients, having curative activity. APIs are often known as bulk pharmaceuticals and most of all APIs are in powder form. Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having a direct effect on disease treatment. APIs are synthesized based on chemical synthesis, fermentation, biotechnological methods or enhanced from the natural source.
Factors such as the growing patient population with chronic conditions increasing the demand for embolization procedures, and technology advancements are driving the market growth, whereas, acquisitions and collaborations and emerging markets are providing growth opportunities for the embolotherapy market.
Cell lines are major tools used in research for studying the normal physiology and biochemistry of cells, the effects of drugs and toxic compounds on the cells, drug screening and development and large scale manufacturing of biological compounds. Cell culture is the process by which cells are grown under controlled conditions derived from microbial or animal cells. Cell lines are subculture of primary culture also known as sub-clone. Cell lines derived from primary cultures have a limited life span, after subsequent cultures, cells with the highest growth capacity dominate which are selected for further cell development. Primary cells are cells that are cultured directly from a subject and have a limited lifespan. An immortalized cell line can proliferate indefinitely either through random mutation or deliberate modification which are useful especially for production of therapeutics.
IQ4I
Latest News
Global pharmaceutical markets are experiencing rapid growth and are projected to continue evolving in the coming years, particularly in the areas of research and development, manufacturing, and formulation. This growth can be attributed to various factors, including the increasing global population, a rise in...
IQ4I
Clientele
Offering solutions to >500 clients from the U.S., Europe, Japan, Korea, Singapore and Australia in realizing the market potential and competitive intelligence across healthcare domains (Medical Technologies, Pharmaceutical, Biotech and Life Sciences).
